Keya Medical
AI for Smarter Healthcare
Latest News
Keya Medical Joins Bayer’s Calantic AI Solution for Radiology
Keya Medical is thrilled to showcase its AI-based augmented CT-FFR analysis through Bayer’s Calantic Digital Solutions platform at ECR2024. Contact us to learn more about our augmentative AI-based CT-FFR analysis.
Subscribe to our monthly newsletter to receive exclusive news updates and medical AI insights.
CT FFR Analysis
Enhancing Diagnosis and Management for Coronary Artery Disease Patients
DEEPVESSEL FFR is a AI-enabled, non-invasive CT fractional flow reserve (FFRCT) analysis. It is an augmentative physiological functional assessment of the coronary arteries using coronary computer tomography angiograms. The software can reduce unnecessary invasive testing, improve patient safety, and lower the cost of cardiovascular testing.
A New Category I CPT code for non-invasive FFR
Category I CPT Code
Starting January 1, 2024, medical practices will implement a new category I CPT code (75580) for non-invasive FFR estimates derived from coronary CT angiography software analysis.
The American College of Cardiology (ACC), American College of Radiology (ACR), and the Society of Cardiovascular Computed Tomography (SCCT) jointly proposed this change to the American Medical Association. It replaces four prior category III CPT codes.
Available in the USA, EMEA, China
FDA-Cleared
2022
NMPA-Approved
2020
CE-Marked
2018
Advantages
Precise
Comprehensive
Cost Saving
Physician Autonomy
Streamlined Workflow
Efficient
FFRCT and DVFFR have transformed my practice, allowing me to provide superior patient care and achieve better outcomes. I am sincerely grateful for this invaluable resource provided by Corazon Imaging.
